Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis

Colloids and Surfaces B: Biointerfaces

Volumn 97, Issue , 2012, Pages 84-89

  Tomoda, Keishiro ^a   Watanabe, Aya ^a   Suzuki, Kenichi ^b   Inagi, Toshio ^b   Terada, Hiroshi ^a   Makino, Kimiko ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b KOWA COMPANY LTD   (Japan)

Author keywords

Biodegradable polymers; Iontophoresis; Nanoparticles; Permeability; PLA); Poly(lactic glycolic) acid (PLGA; Skin; Transdermal drug delivery

Indexed keywords

CHARGED NANOPARTICLES; ENHANCED PERMEABILITY; FREE MOLECULES; GASTROINTESTINAL TRACT; IN-VIVO; INTRAVENOUS ADMINISTRATION; IONTOPHORESIS; METABOLIZATION; NANOCARRIERS; NANOPARTICLE SYSTEMS; NEGATIVE SURFACE CHARGES; PLA); PLGA NANOPARTICLES; POLY(LACTIC/GLYCOLIC) ACID (PLGA; RAT SKIN; SIDE EFFECT; THERAPEUTIC AGENTS; TRANSDERMAL; TRANSDERMAL DELIVERY; TRANSDERMAL DRUG DELIVERY;

BIODEGRADABLE POLYMERS; DISEASES; ELECTROPHORESIS; ELECTROTHERAPEUTICS; MECHANICAL PERMEABILITY; SKIN;

NANOPARTICLES;

ESTRADIOL; NANOPARTICLE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG MUSCLE LEVEL; DRUG PENETRATION; DRUG SCREENING; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; SKIN SURFACE; SURFACE CHARGE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ESTRADIOL; IONTOPHORESIS; LACTIC ACID; MALE; NANOPARTICLES; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION;

RATTUS;

EID: 84861163974     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.04.002     Document Type: Article

References (34)

1. Prince R.L., Smith M., Dick I.M., Price R.I., Webb P.G., Henderson N.K., Arris M.M. N. Engl. J. Med. 1991, 325(17):1189.
2. Deady J. J. Manag. Care Pharm. 2004, 10(1):33.
3. Ramachandran C., Fleisher D. Adv. Drug Deliv. Rev. 2000, 42(3):197.
4. Prausnitz M.R., Langer R. Nat. Biotechnol. 2008, 26(11):1261.
5. Behl C.R., Flynn G.L., Kurihara T., Harper N., Smith W., Higuchi W.I., Ho N.F.H., Pierson C.L. J. Invest. Dermatol. 1980, 75(4):346.
6. Williams A.C., Barry B.W. Adv. Drug Deliv. Rev. 2004, 56(5):603.
7. Wiechers J.W., Zeeuw R.A. Drug Des. Deliv. 1990, 6(2):87.
8. Goodman M., Barry B.W. Int. J. Pharm. 1989, 57(1):29.
9. Ghafourian T., Zandasrar P., Hamishekar H., Nokhodchi A. J. Controlled Release 2004, 99(1):113.
10. Naik A., Pechtold L.A.R., Potts R.O., Guy R.H. J. Controlled Release 1995, 37(3):299.
11. Drakulic B.J., Juranic I.O., Eric S., Zloh M. Int. J. Pharm. 2008, 363(1-2):40.
12. Sapra B., Jain S., Tiwary A.K. AAPS J. 2008, 10(1):120.
13. Masada T., Higuchi W.I., Srinivasan V., Rohr U., Fox J., Behl C., Pons S S. Int. J. Pharm. 1989, 49(1):57.
14. Mudry B., Guy R.H., Delgado-Charro M.B. J. Controlled Release 2006, 111(3):362.
15. Mudry B., Carrupt P.A., Guy R.H., Delgado-Charro M.B. J. Controlled Release 2007, 122(2):165.
16. Praunitz M.R., Bose V.G., Langer R., Weaver J.C. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(22):10504.
17. Ueda H., Sugibayashi K., Morimoto Y. J. Controlled Release 1995, 37(3):291.
18. Henry S., McAllister D.V., Allen M.G., Prausnitz M.R. J. Pharm. Sci. 1998, 87(8):922.
19. Bounoure F., Skiba M.L., Besnard M., Arnaud P., Mallet E., Skiba M. J. Dermatol. Sci. 2008, 52(3):170.
20. Mitragotri S. Pharm. Res. 2000, 17(11):1354.
21. Tsujimoto H., Hara K., Haung C.C., Yokoyama T., Yamamoto H., Takeuchi H., Kawashima Y., Akagi K., Miwa N. J. Soc. Powder Technol. 2004, 41(12):867.
22. Sonavane G., Tomoda K., Sano A., Ohshima H., Terada H., Makino K. Colloids Surf. B: Biointerface 2008, 65(1):1.
23. Miyazaki N., Takahashi A., Kubo W. J. Pharm. Pharm. Sci. 2003, 6(2):238.
24. Tomoda K., Terashima H., Suzuki K., Inagi T., Terada H., Makino K. Colloids Surf. B: Biointerface 2011, 88(2):706.
25. Tomoda K., Terashima H., Suzuki K., Inagi T., Terada H., Makino K. Colloids Surf. B: Biointerface 2012, 92:50.
26. Sahoo S.K., Panyam J., Prabha S., Labhasetwar V. J. Controlled Release 2002, 82(1):105.
27. Stolnik S., Garnett M.C., Davies M.C., Illum L., Bousta M., Vert M., Davis S.S. Colloids Surf. A: Physicochem. Eng. Aspects 1995, 97(3):235.
28. Zambaux M.F., Bonneaux F., Gref R., Maincent P., Dellacherie E., Alonso M.J., Labrude P., Vigneron C. J. Controlled Release 1998, 50(1-3):31.
29. Alvarez-Román R., Naik A., Kalia Y.N., Fessi H., Guy R.H. Eur. J. Pharm. Biopharm. 2004, 58(2):301.
30. Lademann J., Otberg N., Richter H., Meyer L., Audring H., Teichmann A., Thomas S., Knüttel A., Sterry W. Skin Res. Technol. 2007, 13(2):119.
31. Todo H., Kimura E., Yasuno H., Tokudome Y., Hashimoto F., Ikarashi Y., Sugibayashi K. Biol. Pharm. Bull. 2010, 33(8):1394.
32. Alvarez-Román R., Naik A., Kalia Y.N., Guy R.H., Fessi H. J. Controlled Release 2004, 99(1):53.
33. Wu X., Biatry B., Cazeneuve C., Guy R.H. Pharm. Res. 2009, 26(8):1995.
34. Desai M.P., Labhasetwar V., Walter E., Levy R.J., Amidon G.L. Pharm. Res. 1997, 14(11):1568.